In-silico based vaccine development: targeting nucleocapsid protein of SARS-CoV-2.
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
| Päätekijä: | Iva, Yesmine Akter |
|---|---|
| Muut tekijät: | Siam, Mohammad Kawsar Sharif |
| Aineistotyyppi: | Opinnäyte |
| Kieli: | English |
| Julkaistu: |
Brac University
2022
|
| Aiheet: | |
| Linkit: | http://hdl.handle.net/10361/17040 |
Samankaltaisia teoksia
-
An in silico Method to developing an epitope-based peptide vaccination against SARS-CoV-2's Envelope Protein (E)
Tekijä: Intesar, Mohammad Nafees
Julkaistu: (2023) -
Overview of the risk factors, prevention and management of SARS-COV-2
Tekijä: Mustafa, Nashrah
Julkaistu: (2021) -
Omicron, delta, and beta, deadliest among SARS-CoV-2 variants: an in silico analysis
Tekijä: Bosu, Sagar
Julkaistu: (2023) -
Detection of genetic diversity of SARS-CoV-2 in wastewater to monitor COVID-19 transmission
Tekijä: Sarwar, Subyeta Binte
Julkaistu: (2024) -
An in Silico approach to multi-epitope subunit vaccine development against SARS COV-2 using Membrane Glycoprotein
Tekijä: Rafsan, Rian
Julkaistu: (2021)